Study of IBI3020 Treatment in Participants With Late-Stage Solid Tumors
Clinical trial NCT06963281 · RECRUITING
Trial details
- NCT number
- NCT06963281
- Sponsor
- Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-29
- Primary completion
- 2027-12-31
- Enrollment
- 285
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.